الإجابة: سرطان الرئة هو السبب الرئيسي للوفاة بالسرطان حول العالم. حوالي 1.8 مليون شخصٍ يموتون سنويًا بسبب سرطان الرئة حول العالم، أكثر من ضعف العدد الحالات مقارنةً بالسبب الثاني للوفاة بالسرطان سنويًا، سرطان القولون والمستقيم، وفقًا لمنظمة الصحة العالمية.
El cáncer de pulmón es la principal causa de muerte por cáncer en todo el mundo, ya que alrededor de 1,8 millones de personas mueren anualmente debido a este tipo de cáncer lo que corresponde aproximadamente al doble de la cantidad de vidas perdidas debido al cáncer colorrectal que es la segunda causa de muerte por cáncer, según datos de la Organización Mundial de la Salud.
The American Thoracic Society recognizes race is a social construct, not a clinical or biologic construct, and is committed to reducing health disparities and addressing racism in clinical decision-making in medicine.
A short-term quality improvement initiative at Nebraska Medicine quickly reduced the incidence of facial pressure injuries and led to institution-wide adoption of different types of noninvasive oxygen delivery devices.
The Centers for Disease Control and Prevention (CDC) has issued a health advisory about an increase in children being hospitalized with severe respiratory illness who also tested positive for the rhinovirus or enterovirus EV-D68. That particular enterovirus has been associated with acute flaccid myelitis (AFM) – a rare polio-like illness that affects the nerve cells in the gray matter of the spinal cord and could lead to permanent paralysis.
UC San Diego engineers have developed microscopic robots, called microrobots, that can swim around in the lungs, deliver medication and be used to clear up life-threatening cases of bacterial pneumonia. In mice, the microrobots safely eliminated pneumonia-causing bacteria in the lungs and resulted in 100% survival. By contrast, untreated mice all died within three days after infection.
A new service at Children’s Hospital Los Angeles is providing comprehensive care for children with a debilitating post-COVID condition. Some teens can’t get back to the sports they love. Other children can no longer get through a school day—or even walk up a flight of stairs. Still others feel “off”—and anxious and depressed, too.
On World Lung Day, Sept. 25, 2022, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, calls on governments worldwide to address stark global inequalities in respiratory health.
Pascack Valley Medical Center received recertification of its Cardiac and Pulmonary Rehabilitation programs from the American Association of Cardiovascular and Pulmonary Rehabilitation. The certification recognizes the hospital for commitment to improving patient outcomes and quality of life by enhancing standards of care.
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has awarded Jonathan Backer, M.D., professor and chair of molecular pharmacology at Albert Einstein College of Medicine and associate director for shared resources at Montefiore Einstein Cancer Center (MECC), a five-year, $10 million team science (P01) grant to investigate the mechanisms regulating cancer cells that seed tumors in the lungs, a key metastatic site for breast cancer.
Conditions like asthma or COVID-19 make it harder for bodies to absorb oxygen from the lungs. In a proof-of-principle study, University of Washington and University of California San Diego researchers have shown that smartphones are capable of detecting blood oxygen saturation levels down to 70%. This is the lowest value that pulse oximeters should be able to measure, as recommended by the U.S. Food and Drug Administration.
Winners will examine impacts of COVID-19 on lung function, maternal and child health outcomes, underrepresented minority youth, and respiratory recovery.
New study data shows that the immuno-oncology drug, atezolizumab is a safe and effective treatment for stage IB-IIIB non-small cell lung cancer patients prior to lung cancer surgery, according to a new study led by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute as part of the national Lung Cancer Mutation Consortium 3 study.
Researchers found that the survival of patients in this new study was far better – about 80% at three years post treatment and approximately twice as good as that which would be expected with surgery and chemotherapy alone. Study investigators also report data showing that the presence of high numbers of natural killer (NK) cells – a type of immune cell found in the blood before treatment – were associated with poor immunotherapy treatment effectiveness in this study. Patients with high levels of these cells might benefit from the addition of NK-specific therapy.
Nine organizations are joining forces to present the second annual ILD Day on Wednesday, Sept. 14, to drive awareness of interstitial lung disease (ILD).
A potential new treatment combining natural manuka honey with a widely used drug has been developed by scientists at Aston University to treat a potentially lethal lung infection and greatly reduce side effects of one of the current drugs used for its treatment.